The Ark
A blog about our science, the rare disease community and PerlQuests
2018 Parseghian Conference recap
I just attended the 2018 Michael, Marcia, and Christa Parseghian Scientific...
Modeling PMM2 deficiency in Drosophila
An update on the development of PMM2 Drosophila models, and our work to design high...
OI-driven drug discovery
What is the role of OI in drug discovery? Organic Intelligence (OI) is the collective...
Completing an MLIV drug repurposing screen in cells
One of the rare genetic disorders that we at Perlara have been working on is...
Modeling Gaucher disease in worms
In 2016, Perlara and Wylder Nation launched a PerlQuest to find a cure for...
An update on PMM2-CDG yeast models
Drug repurposing screen in haploid PMM2-CDG yeast models During Stage 1 of our...
59th Drosophila Research Conference Recap
My colleague, Tamy Portillo Rodriguez, and I attended the 59th Annual Drosophila...
Our 2018 Q1 burn rate
One of the key values Perlara was founded on is transparency, and a commitment to...
Introducing our newest team members
As our team grows, we would like to take the time to introduce some of the newest...
Launching the Multiple Sulfatase Deficiency PerlQuest
I’m excited to share the latest news! Today we announced our sixth PerlQuest...
Our collaboration with the Undiagnosed Diseases Network
This is my first post in a few months, and a lot has changed at Perlara since then!...
Developing an NGLY1 worm screen
In 2016, Perlara and Grace Science Foundation launched a PerlQuest for NGLY1...
